Literature DB >> 11540095

Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.

L X Yu1, E Lipka, J R Crison, G L Amidon.   

Abstract

For almost a half century scientists have striven to develop a theoretical model capable of predicting oral drug absorption in humans. From the pH-partition hypothesis to the compartmental absorption and transit (CAT) model, various qualitative/quantitative approaches have been proposed, revised and extended. In this review, these models are classified into three categories; quasi-equilibrium models, steady-state models and dynamic models. The quasi-equilibrium models include the pH-partition hypothesis and the absorption potential concept, the steady-state models include the film model and the mass balance approaches, and the dynamic models include the dispersion, mixing tank and CAT models. The quasi-equilibrium models generally provide a basic guideline for understanding drug absorption trends. The steady-state models can be used to estimate the fraction of dose absorbed. The dynamic models predict both the fraction of dose absorbed and the rate of drug absorption and can be related to pharmacokinetic models to evaluate plasma concentration profiles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 11540095     DOI: 10.1016/0169-409x(96)00009-9

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  62 in total

1.  A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts.

Authors:  A Kalampokis; P Argyrakis; P Macheras
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

2.  Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide.

Authors:  R Löbenberg; J Krämer; V P Shah; G L Amidon; J B Dressman
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

3.  Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration.

Authors:  E Nicolaides; M Symillides; J B Dressman; C Reppas
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

4.  The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities.

Authors:  L C Kaus; W R Gillespie; A S Hussain; G L Amidon
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

5.  The mean dissolution time depends on the dose/solubility ratio.

Authors:  Eleni Rinaki; Aristides Dokoumetzidis; Panos Macheras
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

6.  In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation.

Authors:  Bei Yang; David E Smith
Journal:  Pharm Res       Date:  2017-08-02       Impact factor: 4.200

7.  Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.

Authors:  Eleni Rinaki; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 8.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.

Authors:  Arik Dahan; Jonathan M Miller
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

Review 10.  The use of modeling tools to drive efficient oral product design.

Authors:  Neil R Mathias; John Crison
Journal:  AAPS J       Date:  2012-05-30       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.